Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00802100
What this trial is testing

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 21
Not applicableStudy completedNCT00057135
What this trial is testing

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
US Department of Veterans Affairs 150
Not applicableStudy completedNCT00169702
What this trial is testing

The Effect of a Weight Management Program During Treatment With Olanzapine

Who this might be right for
Schizophrenia
Heinrich-Heine University, Duesseldorf 100
Post-approval studies (Phase 4)Ended earlyNCT02435095
What this trial is testing

Antipsychotic Induced Structural and Functional Brain Changes

Who this might be right for
Schizophrenia
RWTH Aachen University 174
Post-approval studies (Phase 4)Study completedNCT02644577
What this trial is testing

Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

Who this might be right for
Bipolar Disorder
China Medical University, China 110
Large-scale testing (Phase 3)Study completedNCT00254202
What this trial is testing

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 593
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Large-scale testing (Phase 3)UnknownNCT00141947
What this trial is testing

Bexarotene Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 15
Large-scale testing (Phase 3)Study completedNCT01235585
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 597
Very early researchStudy completedNCT00456976
What this trial is testing

Efficacy of Selegiline in Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Tabriz University 70
Not applicableStudy completedNCT00528359
What this trial is testing

Β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

Who this might be right for
Schizophrenia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 36
Post-approval studies (Phase 4)Study completedNCT01587118
What this trial is testing

An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder

Who this might be right for
Posttraumatic Stress Disorder
Lori Davis, MD 18
Large-scale testing (Phase 3)UnknownNCT03790345
What this trial is testing

Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics

Who this might be right for
SchizophreniaDrug Induced Movement Disorder, UnspecifiedOxidative Stress
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 45
Large-scale testing (Phase 3)Study completedNCT01051531
What this trial is testing

A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 546
Large-scale testing (Phase 3)Study completedNCT00056472
What this trial is testing

Study of Pharmacotherapy of Psychotic Depression

Who this might be right for
Major Depressive Disorder With Psychotic Features
Weill Medical College of Cornell University 259
Testing effectiveness (Phase 2)Study completedNCT00692185
What this trial is testing

Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

Who this might be right for
Eating Disorders
New York State Psychiatric Institute 23
Not applicableStudy completedNCT00699946
What this trial is testing

Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery

Who this might be right for
Delirium
The New England Baptist Hospital 495
Post-approval studies (Phase 4)Not Yet RecruitingNCT06924255
What this trial is testing

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

Who this might be right for
Schizophrenia Disorders
Collaborative Neuroscience Research, LLC 100
Not applicableUnknownNCT03248180
What this trial is testing

Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States

Who this might be right for
PsychosisRemission
National Taiwan University Hospital 160
Not applicableUnknownNCT06159322
What this trial is testing

Characterizing Response to Antipsychotics in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The Royal Ottawa Mental Health Centre 40
Next Page